<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ratnayake A</submitter><funding>NIAID NIH HHS</funding><funding>Division of Intramural Research, National Institute of Allergy and Infectious Diseases</funding><pagination>3721-3732</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12644162</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Vaccine hesitancy has been a significant concern throughout the COVID-19 pandemic. Vaccine hesitancy can be attributed to lack of confidence in vaccines, complacency about the health threat, or lack of convenience of vaccination. To date, few studies have used methods designed to include populations underrepresented in research when identifying factors associated with vaccine hesitancy.&lt;h4>Methods&lt;/h4>Between January and July 2021, potential participants were recruited from community venues selected through time-location sampling in 15 defined communities in the United States. Study staff administered a questionnaire on demographics, COVID-19 behaviors and attitudes, and vaccination status or intention to consenting individuals. Vaccine hesitancy was analyzed among those</pubmed_abstract><journal>Journal of racial and ethnic health disparities</journal><pubmed_title>Vaccine Hesitancy at Nine Community Sites Across the United States, Early in COVID-19 Vaccine Rollout.</pubmed_title><pmcid>PMC12644162</pmcid><funding_grant_id>UM1AI068619</funding_grant_id><funding_grant_id>UM1 AI068619</funding_grant_id><pubmed_authors>Ratnayake A</pubmed_authors><pubmed_authors>Swaminathan S</pubmed_authors><pubmed_authors>Justman J</pubmed_authors><pubmed_authors>Sobieszczyk ME</pubmed_authors><pubmed_authors>Hirsch-Moverman Y</pubmed_authors><pubmed_authors>Kissinger PJ</pubmed_authors><pubmed_authors>Tapsoba JD</pubmed_authors><pubmed_authors>CoVPN 5002 Study Team</pubmed_authors><pubmed_authors>Ho K</pubmed_authors><pubmed_authors>Skalland T</pubmed_authors><pubmed_authors>Farley JE</pubmed_authors><pubmed_authors>Hernandez JH</pubmed_authors><pubmed_authors>Oluyomi A</pubmed_authors><pubmed_authors>Mayer S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Vaccine Hesitancy at Nine Community Sites Across the United States, Early in COVID-19 Vaccine Rollout.</name><description>&lt;h4>Background&lt;/h4>Vaccine hesitancy has been a significant concern throughout the COVID-19 pandemic. Vaccine hesitancy can be attributed to lack of confidence in vaccines, complacency about the health threat, or lack of convenience of vaccination. To date, few studies have used methods designed to include populations underrepresented in research when identifying factors associated with vaccine hesitancy.&lt;h4>Methods&lt;/h4>Between January and July 2021, potential participants were recruited from community venues selected through time-location sampling in 15 defined communities in the United States. Study staff administered a questionnaire on demographics, COVID-19 behaviors and attitudes, and vaccination status or intention to consenting individuals. Vaccine hesitancy was analyzed among those</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-05T18:54:23.232Z</modification><creation>2026-05-20T03:14:37.539Z</creation></dates><accession>S-EPMC12644162</accession><cross_references><pubmed>39264541</pubmed><doi>10.1007/s40615-024-02172-0</doi></cross_references></HashMap>